High invasiveness of CD133 (+) colonies in lung cancer PDO are also associated with activation of AXL, TGFβ, and JAK1, proofed by effective treatment of AXL inhibitor TP-0903 and JAK inhibitor Ruxolitinib [33]. The gene discussed is PROM1; the disease is lung carcinoma.